Medtech funding reached its low point in the first quarter but will slowly pick back up over the rest of 2023, according to a new Pitchbook report. It noted that this year’s medtech funding total will not come close to the $19.7 billion the sector raised in 2021, and it might even come in below last year’s funding total of $13.5 billion.

Medtech companies should be particularly mindful of the following legal and regulatory compliance issues. This is especially true for companies transitioning to data-based services.

From streamlining long-held manual processes to creating entirely new diagnostic devices, new tech is cropping up all over the medtech industry—resulting in a real-world impact on patients’ quality of life.

Executives from Huma, Abbott, Smith & Nephew and AliveCor share how they are using real world evidence collection to support remote patient monitoring, maximize patient engagement and navigate the regulatory landscape.

Huma plays a vital role in leveraging its digital infrastructure to help medical device companies navigate the regulatory complexities of generating RWE.

The industry faces challenges from inflation to labor shortages, according to an annual report from EY. However, there are grounds for optimism and areas to focus on, such as patching up supply chains.

A look at how tapping real world evidence from medical devices and patients could be a game changer, improving patient-clinician communication, supporting earlier interventions and helping patients manage their condition.

An upcoming webinar sponsored by Huma will highlight three aspects of remote monitoring: real world data collection, supercharging patient engagement and navigating the regulatory landscape. Register today!

A pediatric health system enlisting mixed reality and 3D printing technology illustrates how clinical collaboration and patient education can improve patient outcomes for complex procedures.

BrightInsight developed the Disease Management Solution to help biopharma and medtech companies bring their Software as a Medical Device (SaMD)  to market faster, according to BrightInsight CEO and Co-founder Dr. Kal Patel.

To stay competitive and differentiate themselves, hospitals, physicians and practices must use technology to enhance the patient experience while simultaneously improving outcomes.

Read about news from Equiva, DNA Script, Healthmine, Infermedica, and more.

We are building upon the foundation of digital laparoscopy and adding machine vision, augmented intelligence, and deep learning capabilities.

In order to benefit from the Virtual1Care trend, pharma and medtech companies must ensure that their digital health tools, wrapped around a drug or device, comply with evolving regulations.

Medical technology companies saw 288 deals between June 2020 and June 2021, the highest amount ever since Ernst & Young began tracking it in 2007. VC funding in medtech also reached a high point of $9.1 billion. 

Rune Labs developed software that aggregates brain data, providing insights for clinical care and clinical research. Health systems are starting to adopt the technology, and the startup has now raised $22.8 million to grow that part of the business while also expanding use of the technology in drug development.

Each Organ-Chip is a transparent, flexible microenvironment that contains two parallel chambers that can be configured to grow human cells from an organ of interest, such as the liver, kidney proximal tubule, intestine, lung and brain

The mHUB MedTech Accelerator is a six-month program, based in Chicago, run in partnership with Baxter and Edward-Elmhurst Health Venture Capital. The application deadline is Monday, August 23.

Video from the Health IT and Life Science tracks of our Pitch Perfect contest at INVEST Precision Medicine is now available to view.  

Check out new developments from Kiio, HealthMine, Emulate and Bind Benefits.

Ten companies presented an overview of their businesses in the health IT and life science tracks of Pitch Perfect. Two winners emerged. Here’s a look at who won and why.

Panelists at MedCity INVEST Precision Medicine said startups can gain valuable expertise and experience through the process of seeking out non-dilutive funding.

Docbot CEO Andrew Ritter talked about how the predictive analytics business seeks to shake up how clinicians diagnose gastrointestinal disease by changing the way medical images are analyzed.

Join our live webinar with top MedTech sales experts to learn how to succeed in the digital revolution of medical device and healthcare sales.

In this webinar on Feb. 10,
healthcare experts from Desert Oasis Healthcare and iRhythm Technologies will discuss how Zio monitors, designed to be worn for longer duration than holter monitors, represent a new standard of care in remote cardiac monitoring.

University City Science Center, a Philadelphia-based nonprofit, launched a new accelerator for technology-enabled startups. The first seven companies in its cohort will bring their technical expertise to healthcare.

Last month, medical device company Ivenix received clearance for a new smart infusion pump meant to address the safety issues endemic to the industry with more streamlined and intuitive technology.

Healthcare practitioners will integrate new medtech tools into clinical practice and create more effective and safe procedures globally, but doing so successfully requires the medtech industry to address certain acute healthcare issues.

An expensive failed acquisition, sales force flux, off-label use of a controversial biologics product, a DOJ investigation and nimble competitors chipping away has hobbled Medtronic’s spine business. The purchase of Mazor Robotics aims to be a major reset.

It’s pretty cool to think about how audacious innovation for space may lead to dramatic innovation here on Earth…how an actual moonshot may result in a terrestrial medical moonshot being achieved.